FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions relates to field of medicine and deals with dry powder-like composition for pulmonary introduction, containing microparticles, including glucagon-like peptide (GLP-1) and pharmaceutically acceptable salt of diketopiperazine (DKP). Said composition can be used as pharmaceutical preparation for treating diseases or states, such as, but not limited by, diabetes, cancer and obesity. Method of obtaining composition and method of introduction are also disclosed.
EFFECT: group of inventions provides stability, long-term efficiency and optimal absorption when introduced into organism.
19 cl, 20 ex, 7 tbl, 31 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS, CONTAINING GLUCAGON-LIKE PEPTIDE (GLP-1) | 2007 |
|
RU2409349C2 |
| METHOD FOR PREVENTING GLP-1 SIDE EFFECTS | 2008 |
|
RU2474415C2 |
| ACTIVE SUBSTANCE DELIVERY | 2008 |
|
RU2467741C2 |
| METHOD FOR PREPARING DRUG BASED ON HIGHER AFFINITY OF ACTIVE AGENTS TO CRYSTALLINE MICROPARTICLE SURFACES | 2006 |
|
RU2390325C2 |
| DIKETOPIPERAZIN MICROPARTICLES WITH PARTICULAR AMOUNT OF ISOMERS | 2010 |
|
RU2490026C1 |
| SYSTEMS AND METHODS FOR DRY POWDER DRUG DELIVERY | 2011 |
|
RU2571331C1 |
| SYSTEMS AND METHODS FOR DRY POWDER DRUGS DELIVERY | 2011 |
|
RU2531455C2 |
| METHOD OF IMPROVING PHARMACEUTICAL PROPERTIES OF PARTICLES, CONTAINING DIKETOPIPERAZINE AND ACTIVE AGENT | 2007 |
|
RU2403059C2 |
| DRY POWDER DRUG DELIVERY SYSTEMS AND METHODS | 2013 |
|
RU2650035C2 |
| METHOD FOR PREPARING DRUG COMPOSITION BASED ON INCREASING ACTIVE AGENT AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES | 2010 |
|
RU2443414C2 |
